Allen C. Ho

Allen C. Ho, MD, FACS is Attending Surgeon and Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. He maintains special interests in macular diseases, diabetic retinopathy, surgical retinal diseases, and clinical trials investigating new treatments for vitreoretinal diseases including gene and cell therapies and new surgical drug delivery devices and techniques. His experience includes collaborative translational and clinical trial clinical research with expertise in study design, methodological testing, data analyses, surgical instrumentation and procedure development, execution and communication of these studies and their study results, and commercialization and patient access to care. He is past President of The Retina Society and a leader of Eyecelerator, the largest ophthalmic innovation meeting in the world.

He has deep experience in translational clinical research and been Study Chair, Steering Committee Member or Principal Investigator of over 70 clinical trials. Dr. Ho has served on the US FDA Ophthalmic Device Panel, AAO Innovation Task Force, AAO Ophthalmic Retina Technology Assessment Committee, AAO Retina Measures Group, AAO IRIS Registry Committee and is past Chair of the AAO Retina Subspecialty Days.

Dr. Ho has authored over 300 peer reviewed publications and several textbooks and is Editor-in-Chief of Current Opinion in Ophthalmology and Chief Medical Editor of Retina Today. He has received distinguished awards from the American Academy of Ophthalmology, multiple retina societies and the American Diabetes Association. He is a perennial awardee of national Castle Connolly awards and has been named to The Ophthalmologist Power 100 most influential eye specialists in the world on multiple occasions, most recently 2023.